Sort
59,101 grants matching “hypertension”
Ocular Inflammatory Mediators in the Pathophysiology of Diabetic Retinopathy
$432,500Stephen Jae Kim · Vanderbilt University Medical Center · R01 · FY2020 · EY
Transcriptional Regulation by Angiotensin II in Vascular Smooth Muscle Cells
$432,500Rama Natarajan · Beckman Research Institute/City Of Hope · R01 · FY2019 · HL
Transcriptional Regulation by Angiotensin II in Vascular Smooth Muscle Cells
$432,500Rama Natarajan · Beckman Research Institute/City Of Hope · R01 · FY2017 · HL
Transcriptional Regulation by Angiotensin II in Vascular Smooth Muscle Cells
$432,500Rama Natarajan · Beckman Research Institute/City Of Hope · R01 · FY2018 · HL
APOL1 variants: Understanding the basis of disparities in rates of kidney disease
$432,500Martin R. Pollak · Beth Israel Deaconess Medical Center · R01 · FY2019 · MD
Ocular Inflammatory Mediators in the Pathophysiology of Diabetic Retinopathy
$432,500Stephen Jae Kim · Vanderbilt University Medical Center · R01 · FY2024 · EY
Renal sodium-bicarbonate co-transporter (SLC4A5) activity in human subjects with salt sensitivity of blood pressure: intrarenal mechanisms and role in blood pressure regulation
$432,469Robert Munson Carey · University Of Virginia · P01 · FY2019 · HL
A Novel Neuroprotective Approach for Glaucoma
$432,467Katalin T Prokai · University Of North Texas Hlth Sci Ctr · R01 · FY2025 · EY
A Novel Neuroprotective Approach for Glaucoma
$432,467Katalin T Prokai · University Of North Texas Hlth Sci Ctr · R01 · FY2023 · EY
A Novel Neuroprotective Approach for Glaucoma
$432,467Katalin T Prokai · University Of North Texas Hlth Sci Ctr · R01 · FY2024 · EY
2'-Fluorophosphophloretin (2FP)in the Treatment of Chronic Renal Failure
$432,425Brian Edward Peerce · Duophos, Llc · R44 · FY2014 · DK
Evaluation of Invertebrate Hemoglobins as Effective, Safe, and Ultra-Stable Blood Substitutes
$432,392Jacob James Elmer · Villanova University · R15 · FY2017 · HL
Aspirin and Simvastatin--Pulmonary Arterial Hypertension
$432,391Steven M Kawut · Columbia University Health Sciences · R01 · FY2006 · HL
Functional Studies of Fully Active Na, K-ATPase
$432,359State University New York Stony Brook · R01 · FY2004 · DK
Glomerular and Tubular Function in the Diabetic Kidney
$432,346Scott C. Thomson · Veterans Medical Research Fdn/San Diego · R01 · FY2021 · DK
Glomerular and Tubular Function in the Diabetic Kidney
$432,346Scott C. Thomson · Veterans Medical Research Fdn/San Diego · R01 · FY2020 · DK
Glomerular and Tubular Function in the Diabetic Kidney
$432,346Scott C. Thomson · Veterans Medical Research Fdn/San Diego · R01 · FY2019 · DK
NEDD9-SMAD3, fibrinolysis, and chronic thromboembolic pulmonary hypertension
$432,332Bradley Maron · Brigham And Women'S Hospital · R01 · FY2020 · HL
NEDD9-SMAD3, fibrinolysis, and chronic thromboembolic pulmonary hypertension
$432,332Bradley Maron · Brigham And Women'S Hospital · R01 · FY2021 · HL
NEDD9-SMAD3, fibrinolysis, and chronic thromboembolic pulmonary hypertension
$432,332Bradley Maron · University Of Maryland Baltimore · R01 · FY2023 · HL
NEDD9-SMAD3, fibrinolysis, and chronic thromboembolic pulmonary hypertension
$432,332Bradley Maron · Brigham And Women'S Hospital · R01 · FY2022 · HL
Statistical Methods for Large Scale Microbiome Studies of Cardiovascular Disease Risk
$432,189Michael Chiao-An Wu · Fred Hutchinson Cancer Center · R01 · FY2024 · HL
Ionic mechanisms of toluene cerebrovascular actions
$432,183Alejandro M Dopico · University Of Tennessee Health Sci Ctr · R01 · FY2024 · ES
Ionic mechanisms of toluene cerebrovascular actions
$432,183Alejandro M Dopico · University Of Tennessee Health Sci Ctr · R01 · FY2025 · ES
Ionic mechanisms of toluene cerebrovascular actions
$432,183Alejandro M Dopico · University Of Tennessee Health Sci Ctr · R01 · FY2023 · ES